An artificial pancreas developed by researchers at the University of Cambridge has been granted approval by the USA’s Food and Drug Administration (FDA) for use by individuals with type 1 diabetes aged two and older, including during pregnancy.
The National Institute for Health and Care Excellence (NICE) has today (7 November 2023) recommended hybrid closed loop systems including the CamAPS FX app for use in managing type 1 diabetes, meaning that even more people living with the disease will be able to use this life-changing app.
Cambridge scientists have successfully trialled an artificial pancreas for use by patients living with type 2 diabetes. The device – powered by an algorithm developed at the University of Cambridge – doubled the amount of time patients were in the target range for glucose compared to standard treatment and halved the time spent experiencing high glucose levels.
An artificial pancreas developed by Cambridge researchers is helping protect very young children with type 1 diabetes at a vulnerable time of their lives. New research shows that it is both safe to use and more effective at managing their blood sugar levels than current technology.
An artificial pancreas could soon help those people living with type 2 diabetes who also require kidney dialysis. Tests led by the University of Cambridge and Inselspital, University Hospital of Bern, Switzerland, show that the device can help patients safely and effectively manage their blood sugar levels and reduce the risk of low blood sugar levels.
The world’s first licensed, downloadable artificial pancreas app for people with type 1 diabetes launches today, based on over a decade of research by Professor Roman Hovorka at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust.
Nine researchers from the University of Cambridge are among 46 world leading UK researchers who have been elected to the prestigious Fellowship of the Academy of Medical Sciences.
An international trial to test whether an artificial pancreas can help young children manage their type 1 diabetes will begin next year, thanks to a major grant awarded by the European Commission.
Technology assisting people with type 1 diabetes edges closer to perfection.
The first natural birth to a mother with diabetes who has been fitted with an artificial pancreas took place this week. The device has been developed by researchers at the University of Cambridge.
© 2024 University of Cambridge